Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Revolut hires former SocGen boss Oudea as West Europe chairman

Fri, 05th Sep 2025 06:00

PARIS, Sept 5 (Reuters) - London-based financial technology company Revolut has hired Frederic Oudea, the former CEO of France's Societe Generale, as chairman of its Western Europe hub in Paris, as it prepares to apply for a banking licence in the country.

The hire underscores Revolut's aggressive expansion, as it enlists a heavyweight of France's corporate establishment.

The former SocGen chief, who also chairs pharmaceuticals giant Sanofi, adds clout as the fast-growing challenger bank seeks to scale its services and credibility.

Revolut announced in May that it planned to invest 1 billion euros ($1.2 billion) over the next three years expanding in France, opening a new office in Paris for its Western Europe operations.

Revolut is the biggest of a number of European financial services apps founded in the past decade, with more than 60 million customers around the world but no physical branches.

It is in the process of a share sale valuing the company at $75 billion, up from $45 billion in August 2024.

Revolut gained a banking licence with restrictions in Britain in 2024, after a three-year process, and expects to start operating as a UK bank this year. The company has a Lithuanian banking licence, which it can use as a passport into the European Union, enabling it to sell products in the bloc.

A spokesperson for Revolut previously told Reuters that having a second banking licence in the bloc would allow it to build closer relationships with regulators and offer services that are more tailored for its customers in France.

Revolut is also considering buying a U.S. lender to gain a licence in the United States, according to recent media reports.

A spokesperson declined to comment on the reports.

Oudea is not the first banking leader to move to a challenger bank. In August, German online bank N26 announced a former member of the Bundesbank executive board, Andreas Dombret, as the new chair of its supervisory board. ($1 = 0.8542 euros) (Reporting by Elizabeth Howcroft, Editing by Louise Heavens)

Société Générale Sanofi

Shares in this article

Related News

Sanofi says rare lung disease drug outperforms standard care in trial
18 May 2026

Sanofi says rare lung disease drug outperforms standard care in trial

* Therapy raised key lung protein more than ​standard ⁠care in trial

REFILE-FDA drug center head expected to leave after commissioner's exit, sources say
16 May 2026

REFILE-FDA drug center head expected to leave after commissioner's exit, sources say

* Hoeg's departure comes amid broader shakeup of ​health agency

Pharmaceuticals Merck + 2 more shares
European shares log biggest monthly gains in over a year
30 Apr 2026

European shares log biggest monthly gains in over a year

* Defense stocks ​lead gains, aided by Rolls-Royce

Market News Rolls-Royce + 6 more shares